Conference Coverage: ESMO 2023 – Focus on Squamous Cell Carcinoma of the Head and Neck (SCCHN)

Global clinical experts discuss perspectives on current treatment strategies and emerging therapies in advanced SCCHN

October 31, 2023


Amanda Psyrri, MD, PhD

Attikon University Hospital, Chaidari, Greece

Faculty Members

Christophe Le Tourneau, MD, PhD
Institut Curie, Paris, France

Ulrich Keilholz, MD, PhD
Charité Comprehensive Cancer Center, Berlin, Germany

Maura Gillison, MD, PhD
MD Anderson Cancer Center, Houston, TX, USA

Tanguy Seiwert , MD
Johns Hopkins School of Medicine, Baltimore, MD, USA

Robert L. Ferris, MD, PhD
UPMC Hillman Cancer Center, Pittsburgh, PA, USA

Sample Report

Start discovering the insights

View Report


  • Early and Locally Advanced SCCHN – Current Treatment Strategies and Novel Therapeutic Approaches
  • Metastatic SCCHN – Focus on Targeted Treatment Strategies
  • Metastatic SCCHN – Focus on Immune Checkpoint Therapy Combinations (IO, BsAbs, and Vaccines)
  • Metastatic SCCHN – Focus on Immune Checkpoint Therapy Combinations (Oncolytics, ADC, Others)
  • SCCHN – Learnings From Real-World Data

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.